Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ethicon, Inc.
This is a single blind, randomized, multi-center controlled study evaluating the safety and effectiveness of EVICEL® when used as an adjunct to gastrointestinal (GI) surgery.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects undergoing primary elective GI surgery
Subjects ≥ 18 years of age who are willing to participate in the study and provide written informed consent prior to any study-related procedures
You may not be if
Avastin use within 30 days prior to surgery;
Known hypersensitivity to the human blood products or the components of the investigational product;
Female subjects who are pregnant or nursing;
Exposure to another investigational drug or device in a clinical trial within 30 days prior to surgery or planned/intended for the 90 day follow up period after surgery.
Clareo Health | The EVICEL® Gastrointestinal Study
